Cite
HARVARD Citation
Galot, R. et al. (2021). A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial. European journal of cancer. pp. 17-26. [Online].